Give Back Health Innovation Foundation Supports ScarDx to Advance Non-Invasive Kidney Care

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeBusiness Wire News ReleasesPMN Press ReleasesThis section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Give Back Health Innovation Foundation Supports ScarDx to Advance Non-Invasive Kidney CareAuthor of the article:Canadian-developed, AI-powered imaging technology aims to redefine kidney care – delivering better outcomes at lower costs while easing pressure on healthcare systemsTHIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountTORONTO — Give Back Health Innovation Foundation ( Give Back), a Canadian philanthropic network advancing public health through innovation and technology, today announced its partnership with ScarDx, a newly formed Ontario health technology company developing a non-invasive way to measure kidney scarring, or fibrosis. Through this partnership, Give Back will provide philanthropic capital aligned with its mission and operating model to support the company as it advances its commercialization efforts.This advertisement has not loaded yet, but your article continues below.Emerging from research at the Keenan Research Centre for Biomedical Science at St. Michael’s Hospital, a site of Unity Health Toronto, ScarDx leverages artificial intelligence (AI) to analyze data from ultrasound images. Its goal is to give clinicians greater visibility into kidney scarring while reducing reliance on invasive kidney biopsies.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try again“At Give Back, we believe Canadian innovation can solve real-world health challenges and create lasting value for patients and our healthcare systems,” said Greg Wolfond, Co-founder at Give Back Health Innovation Foundation. “ScarDx is a powerful example of what’s possible when world-class research is supported and scaled in Canada. We’re proud to help accelerate this groundbreaking Canadian innovation in non-invasive kidney care through our funding model that puts health outcomes ahead of financial returns.” Key highlights and opportunities of ScarDx for Canadian healthcare:AI-driven: Uses AI and existing ultrasound technology to help clinicians see and measure kidney fibrosis non-invasively.Global potential: Kidney disease affects approximately one in 10 people in Canada and around the world, creating a significant need for more accessible diagnostic tools.Growing Canadian health innovation: ScarDx is translating Ontario-based research into a scalable Canadian health technology with potential at home and globally.Powered by Give Back: A new model designed to help promising Canadian health innovations move from research toward commercialization while creating lasting value for Canada.“We’re very excited to partner with Give Back, whose unique funding model leverages donor contributions to support Canadian health innovation ventures like ours,” said ScarDx co-founders Drs. Darren Yuen, nephrologist and Eno Hysi, physicist, both at St. Michael’s Hospital. “Doctors have limited ways to safely see the extent of kidney scarring and our goal is to close that diagnostic blind spot, giving clinicians important information to inform treatment decisions while reducing reliance on invasive and costly biopsies. This technology has the potential to improve the lives of people with kidney disease.”The research behind ScarDx was recognized in 2024 when Yuen and Hysi won the Keenan Award for Medical Discovery through St. Michael’s Hospital Foundation’s research competition Angels Den for their project, No More Needles: A Non-Invasive Way to See Kidney Scarring. The recognition and funding helped fuel research that is now moving toward commercialization through ScarDx.This advertisement has not loaded yet, but your article continues below.About Give Back Health Innovation FoundationGive Back Health Innovation Foundation is a Canadian not-for-profit advancing public health through innovation and technology. Give Back connects philanthropy with promising Canadian health ventures, helping Canadian discoveries reach commercialization and scale while strengthening Canada’s healthcare and life-sciences ecosystem. For more information: givebackhealth.org Visit our public directory of Canadian health-innovation ventures supported by, or seeking support from, the Give Back network here.View source version on businesswire.com: This advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.